The Laboratory of Biomaterials, Drug Delivery, and Bionanotechnology, led by Professor Nicholas A. Peppas, has been the leading group and pacesetter in the fields of drug delivery and controlled release, which have developed into mature areas of scholarly and applied research.

Our recent research has concentrated in three major areas: nanoparticle-mediated drug delivery, protein-recognitive biosensors, and hydrogel scaffold design for regenerative medicine and tissue engineering. We focus primarily on fundamental materials-based approaches to solving critical healthcare problems. Current clinical targets include early detection of Sjörgen’s syndrome, treatment of gastrointestinal diseases, oral delivery for multiple sclerosis and diabetes treatment, healing non-union bone fractures, and innovative approaches for treating bone marrow-associated cancers, glioblastoma multiforme, and colorectal cancer.